The American pharmaceutical company Merck, which in Brazil is known as MSD, announced on Friday (1) that it intends to request the approval in the US of a remedy against Covid-19: o molnupiravir. A study by the company showed that the drug reduced by about 19% the possibility of hospitalization or death in patients at risk of developing severe forms of the disease.
If If approved, a molnupiravir will learn how to make the first medicine in the pill with proven efficacy to treat the disease, unlike medications such as electronic hydroxychloroquine and ivermectin, advertised by pandemic deniers.
The episode performs One Morning Coffee this Monday (4) has a participation perform reporter on the science of a Folha electronic presenter perform podcast Reply Imune, Reinaldo Jos Lopes. He explains the difficulty of producing remedies against Covid-19 electronic as they could help fight the pandemic.
Or an episode:
The program on audio published is zero Spotify, service on streaming partner of a Folha in the electronic initiative that specializes in music, electronic video podcast. You can listen to the episode by clicking below. To access the app, simply register for free.
One Morning Coffee published on Monday to Friday, always zero start perform day. The episode presented by journalists Mag Flores electronic Maurcio Meireles. The script had the participation of Angela Boldrini. Her production, by Jessica Maes, Laila Mouallem electronic Victor Lacombe. Sound editing by Thom Granemann electronic Natlia Silva.